scispace - formally typeset
S

Stephen C. Textor

Researcher at Mayo Clinic

Publications -  312
Citations -  22845

Stephen C. Textor is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Kidney & Renal artery stenosis. The author has an hindex of 68, co-authored 308 publications receiving 20702 citations. Previous affiliations of Stephen C. Textor include Cleveland Clinic & University of Rochester.

Papers
More filters
Journal ArticleDOI

Resistant Hypertension: Diagnosis, Evaluation, and Treatment A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

TL;DR: Expanding the understanding of the causes of resistant hypertension and thereby potentially allowing for more effective prevention and/or treatment will be essential to improve the long-term clinical management of this disorder.
Journal ArticleDOI

Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

TL;DR: The overall incidence of ARF after PCI is low, and diabetic patients with baseline Cr values <2.0 mg/dL are at higher risk than nondiabetic patients, whereas all patients with a serum Cr >2.
Journal ArticleDOI

Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

TL;DR: Expanding the understanding of the causes of resistant hypertension and thereby potentially allowing for more effective prevention and/or treatment will be essential to improve the long-term clinical management of this disorder.

AHA Scientific Statement Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

TL;DR: The diagnosis of resistant hypertension requires use of good blood pressure technique to confirm persistently elevated blood pressure levels, including lack of blood pressure control secondary to poor medication adherence or white coat hypertension, must be excluded as mentioned in this paper.
Journal ArticleDOI

Renal-Artery Stenosis

TL;DR: The goals for treating patients with RAS are to reduce cardiovascu-lar morbidity and mortality attributable to elevated arterial pressure and to preserve renal function beyond critical stenosis and to identify progressive occlusive disease and to determine appropriate timing for vascular intervention.